Research output per year
Research output per year
Research output
- 2 Article
-
Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma
JULIET Investigators, 3 Jan 2019, In: New England journal of medicine. 380, 1, p. 45-56 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2443 Citations (Scopus) -
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
Van Den Neste, E., André, M., Gastinne, T., Stamatoullas, A., Haioun, C., Belhabri, A., Reman, O., Casasnovas, O., Ghesquieres, H., Verhoef, G., Claessen, M-J., Poirel, H. A., Copin, M-C., Dubois, R., Vandenberghe, P., Stoian, I-A., Cottereau, A. S., Bailly, S., Knoops, L. & Morschhauser, F., 2018, In: Haematologica. 103, 5, p. 840-848 9 p.Research output: Contribution to journal › Article › Academic › peer-review
39 Citations (Scopus)